These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 7055025)
1. Cardiac drug overdose. Drake CE Am Fam Physician; 1982 Jan; 25(1):181-7. PubMed ID: 7055025 [TBL] [Abstract][Full Text] [Related]
2. Series on pharmacology in practice. 2. Antiarrhythmic drug therapy. Federman J; Vlietstra RE Mayo Clin Proc; 1979 Aug; 54(8):531-42. PubMed ID: 459565 [TBL] [Abstract][Full Text] [Related]
3. [Pharmacokinetics of anti-arrhythmics. 2. Clinical applications]. Lévy RH; Lévy S; Bricaud H Arch Mal Coeur Vaiss; 1980 Oct; 73(10):1229-35. PubMed ID: 6778416 [TBL] [Abstract][Full Text] [Related]
4. Poisoning due to class IA antiarrhythmic drugs. Quinidine, procainamide and disopyramide. Kim SY; Benowitz NL Drug Saf; 1990; 5(6):393-420. PubMed ID: 2285495 [TBL] [Abstract][Full Text] [Related]
5. Pharmacologic basis for the treatment of cardiac arrhythmias. Gelband H; Rosen MR Pediatrics; 1975 Jan; 55(1):59-67. PubMed ID: 1089243 [No Abstract] [Full Text] [Related]
6. [Pharmacokinetics of the principal anti-arrhythmia agents]. Derrida JP; Chiche P Coeur Med Interne; 1978; 17(1):79-88. PubMed ID: 25160 [No Abstract] [Full Text] [Related]
7. Individualization of dosage of antiarrhythmic drugs. Kessler KM Med Clin North Am; 1974 Sep; 58(5):1019-26. PubMed ID: 4609363 [No Abstract] [Full Text] [Related]
8. Clinical pharmacokinetics of antiarrhythmic drugs. Harrison DC; Meffin PJ; Winkle RA Prog Cardiovasc Dis; 1977; 20(3):217-42. PubMed ID: 335439 [No Abstract] [Full Text] [Related]
9. [Clinical pharmacology of anti-arrhythmia agents. I. Quinidine, procainamide and disopyramide]. Witkowska M Kardiol Pol; 1981; 24(7):505-17. PubMed ID: 7024612 [No Abstract] [Full Text] [Related]
11. Antiarrhythmic drug therapy. Stanford JL; Felner JM; Arensberg D Am J Nurs; 1980 Jul; 80(7):1288-95. PubMed ID: 6901576 [No Abstract] [Full Text] [Related]
12. [Determination of plasma concentrations of anti-arrhythmia agents]. Flouvat B Arch Mal Coeur Vaiss; 1981 Dec; 74 Spec No():47-55. PubMed ID: 6803701 [TBL] [Abstract][Full Text] [Related]
13. [Interaction of phenytoin with propranolol, procainamide and digoxin]. Halawa B Pol Tyg Lek; 1985 Jul; 40(28):790-3. PubMed ID: 4059101 [No Abstract] [Full Text] [Related]
14. Therapeutic drug monitoring of antiarrhythmic agents. Brown JE; Shand DG Clin Pharmacokinet; 1982; 7(2):125-48. PubMed ID: 7039925 [No Abstract] [Full Text] [Related]
16. [Pharmacokinetics of the principal anti-arrhythmic drugs. Measurement of their blood levels]. Cheymol G; Bernheim C; Jaillon P Therapie; 1976; 31(2):149-65. PubMed ID: 951673 [No Abstract] [Full Text] [Related]
17. Metabolites of antiarrhythmic drugs: are they clinically important? Kates RE Ration Drug Ther; 1986 May; 20(5):1-5. PubMed ID: 3097754 [No Abstract] [Full Text] [Related]
18. Clinical pharmacokinetics of some antiarrhythmic drugs. Ochs HR; Greenblatt DJ; Bodem G Herz; 1979 Aug; 4(4):330-43. PubMed ID: 391683 [No Abstract] [Full Text] [Related]
19. Practical aspects in the utilization of commonly used antiarrhythmic drugs. Waldo AL; Storm OG J Med Assoc State Ala; 1974 Jun; 43(12):739-42. PubMed ID: 4847300 [No Abstract] [Full Text] [Related]
20. [Indications and limitations of anti-arrhythmic drugs]. Fica V; Panaitescu G; Mătrescu F; Popescu EA Med Interna (Bucur); 1971 May; 23(5):523-36. PubMed ID: 5567980 [No Abstract] [Full Text] [Related] [Next] [New Search]